Today's Veterinary Practice

NOV-DEC 2017

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: http://todaysveterinarypractice.epubxp.com/i/891985

Contents of this Issue

Navigation

Page 70 of 77

A Gift ith Special Meaning A Gift With Special Meaning This Holiday Season Adopt-A-Manatee ® Call 1-800-432-JOIN (5646) savethemanatee.org Photo © David Schrichte PEER REVIEWED 67 NOVEMBER/DECEMBER 2017 ■ TVPJOURNAL.COM age. Although the test is low yield, he should be screened for systemic hypertension. References 1. Wagner T, Fuentes VL, Payne JR, et al. Comparison of auscultatory and echocardiographic findings in healthy adult cats. J Vet Cardiol 2010;12(3):171-182. 2. Hogan DF, Fox PR, Jacob K, et al. Secondary prevention of cardiogenic arterial thromboembolism in the cat: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT). J Vet Cardiol 2015;17 Suppl 1:S306-S317. 3. Ward JL, Lisciandro GR, Keene BW, et al. Accuracy of point-of-care lung ultrasonography for the diagnosis of cardiogenic pulmonary edema in dogs and cats with acute dyspnea. JAVMA 2017;250(6):666- 675. 4. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS 2010;5(6):463-466. 5. Liquori ME, Christenson RH, Collinson PO, Defilippi CR. Cardiac biomarkers in heart failure. Clin Biochem 2014;47(6):327-337. 6. Connolly DJ, Cannata J, Boswood A, et al. Cardiac troponin I in cats with hypertrophic cardiomyopathy. J Feline Med Surg. 2003;5(4):209- 216. 7. Herndon WE, Kittleson MD, Sanderson K, et al. Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med 2002;16(5):558- 564. 8. Connolly DJ, Brodbelt DC, Copeland H, et al. Assessment of the diagnostic accuracy of circulating cardiac troponin I concentration to distinguish between cats with cardiac and non-cardiac causes of respiratory distress. J Vet Cardiol 2009;11(2):71-78. 9. van Kimmenade RRJ, Januzzi JL. The evolution of the natriuretic peptides – current applications in human and animal medicine. J Vet Cardiol 2009;11 Suppl 1:S9-S21. 10. Connolly DJ, Soares Magalhaes RJ, Syme HM, et al. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 2008;22:96-105. 11. Fox PR, Rush JE, Reynolds CA, et al. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. J Vet Intern Med 2011;25(5):1010-1016. 12. Wess G, Daisenberger P, Mahling M, et al. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Vet Clin Pa thol 2011;40(2):237-244. 13. Connolly DJ, Soares Magalhaes RJ, Fuentes VL, et al. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non- cardiac causes of respiratory distress. J Vet Cardiol. 2009;11 Suppl 1:S41-S50. 14. Fox PR, Oyama MA, Reynolds C, et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J Vet Cardiol. 2009;11 Suppl 1:S51-S61. 15. Janda S, Swiston J. Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta- analysis. BMC Pulm Med 2010;10(1):58. 16. Meurs KM, Sanchez X, David RM, et al. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 2005;14(23):3587-3593. 17. Meurs KM, Norgard MM, Ederer MM, et al. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 2007;90(2):261-264. 18. Li RHL, Stern JA, Ho V, et al. Platelet activation and clopidogrel effects on ADP-induced platelet activation in cats with or without the A31P mutation in MYBPC3. J Vet Intern Med 2016;30(5):1619-1629. 19. Wess G, Schinner C, Weber K, et al. Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine coon and other breed cats. J Vet Intern Med 2010;24(3):527-532. 20. Borgeat K, Stern J, Meurs KM, et al. The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats. J Vet Cardiol 2015;17 Suppl 1:S258-S267.

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - NOV-DEC 2017